We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Metabolite itaconate in host immunoregulation and defense
Summary
Researchers reviewed how itaconate — a small molecule produced naturally by immune cells during infection — acts as a master regulator of inflammation and oxidative stress in macrophages (the body's frontline immune defenders). Understanding itaconate's pathways may open new treatment strategies for inflammatory diseases and cancer.
Metabolic states greatly influence functioning and differentiation of immune cells. Regulating the metabolism of immune cells can effectively modulate the host immune response. Itaconate, an intermediate metabolite derived from the tricarboxylic acid (TCA) cycle of immune cells, is produced through the decarboxylation of cis-aconitate by cis-aconitate decarboxylase in the mitochondria. The gene encoding cis-aconitate decarboxylase is known as immune response gene 1 (IRG1). In response to external proinflammatory stimulation, macrophages exhibit high IRG1 expression. IRG1/itaconate inhibits succinate dehydrogenase activity, thus influencing the metabolic status of macrophages. Therefore, itaconate serves as a link between macrophage metabolism, oxidative stress, and immune response, ultimately regulating macrophage function. Studies have demonstrated that itaconate acts on various signaling pathways, including Keap1-nuclear factor E2-related factor 2-ARE pathways, ATF3-IκBζ axis, and the stimulator of interferon genes (STING) pathway to exert antiinflammatory and antioxidant effects. Furthermore, several studies have reported that itaconate affects cancer occurrence and development through diverse signaling pathways. In this paper, we provide a comprehensive review of the role IRG1/itaconate and its derivatives in the regulation of macrophage metabolism and functions. By furthering our understanding of itaconate, we intend to shed light on its potential for treating inflammatory diseases and offer new insights in this field.
Sign in to start a discussion.
More Papers Like This
Polystyrene Nanoplastics Increase Macrophage Bactericidal Activity Through a Mechanism Involving Reactive Oxygen Species and Itaconate
Researchers found that polystyrene nanoplastics internalised by macrophages accumulated in endosomes, lysosomes, and the endoplasmic reticulum, enhancing bacterial killing through a mechanism involving increased reactive oxygen species production and itaconate signalling. The results suggest that nanoplastic exposure may paradoxically boost certain innate immune functions.
Polystyrene Nanoplastics Increase Macrophage Bactericidal Activity Through a Mechanism Involving Reactive Oxygen Species and Itaconate
Researchers found that polystyrene nanoplastics are internalized by macrophages and accumulate in endosomes, lysosomes, and the endoplasmic reticulum, where they unexpectedly increase the cells' ability to kill bacteria. The study identified a mechanism involving reactive oxygen species and itaconate production, suggesting that nanoplastic exposure can alter immune cell function in ways that may have broader implications for immune responses.
Tumour-associated macrophages: versatile players in the tumour microenvironment
This review explores tumour-associated macrophages, immune cells that play complex and sometimes contradictory roles in cancer, both helping tumours grow and fighting them. Researchers describe newly discovered behaviors of these cells, including their ability to transform into other cell types. The study highlights the potential of targeting these macrophages as a strategy in cancer immunotherapy.
Polystyrene microplastics induce an immunometabolic active state in macrophages
Researchers investigated how macrophages, the immune cells that act as first-line defense in the gut and lungs, respond metabolically to polystyrene microplastic particles. The study found that phagocytosis of microplastics induced an immunometabolic active state in macrophages, suggesting that microplastic exposure may alter immune cell metabolism in ways relevant to understanding potential health effects.
Santacruzamate A Alleviates Pain and Pain-Related Adverse Emotions through the Inhibition of Microglial Activation in the Anterior Cingulate Cortex
Researchers found that Santacruzamate A, a natural compound from marine cyanobacteria, reduced chronic pain and pain-related anxiety in mice by calming overactive immune cells in the brain. The compound works by inhibiting an enzyme involved in inflammation, which in turn reduces levels of inflammatory signals. The study suggests this marine-derived compound could be a candidate for developing new pain treatments.